In summary, we immunolocalized ARHGAP15 and Rac GAP in human breast carcinoma tissues, and ARHGAP15 immunoreactivity was significantly correlated with AR LI, decreased risk of recurrence, and better prognosis for the patients. Here, AR is linked to breast carcinoma.